Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribociclib + Letrozole in HR+ HER2- Advanced Breast Cancer
NCT02941926Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2016
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 38
01
Overview
A Phase 3 trial of ribociclib in breast cancer, sponsored by Novartis. Started Nov 2016; status: completed.
02
Drugs
ribociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02941926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02941926.